Skip to main content

Relapsing Multiple Sclerosis FILIOS

Status: Closed to Enrollment

Study Details

View study details on clinicaltrials.gov.

Locations

  • Berkeley

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

An Open-label, Randomized, Parallel Group, Non-inferiority Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab, Followed by Extended Treatment in Participants With Relapsing Multiple Sclerosis (COMB157Q12301 FILIOS)

Deepak Soneji
Deepak Soneji
Principal investigator
View Profile

Co-investigators

Joanna A. Cooper, Lynn Jehle

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?